Maeva Zysman

Inserm U955 IMRB, UMR U955, Équipe 04, Et Université Paris Est
Creteil, 94010, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 106 publications

Combined emphysema and cancer, from radiology to prognosis in patients treated by immunotherapy: An ancillary study of a prospective multicenter phase II IFCT-1802 SAVIMMUNE.

Combined emphysema and cancer, from radiology to prognosis in patients treated by immunotherapy: An ancillary study of a prospective multicenter phase II IFCT-1802 SAVIMMUNE.

Journal: Respiratory medicine and research

Published: May 19, 2026

Treatment Sequencing and Immunotherapy Rechallenge in Advanced Non-Small-Cell Lung Cancer: Final 24-Month Real-World Results from the French LIST Study.

Treatment Sequencing and Immunotherapy Rechallenge in Advanced Non-Small-Cell Lung Cancer: Final 24-Month Real-World Results from the French LIST Study.

Journal: Oncology and therapy

Published: March 06, 2026

Low-carbon therapeutics in cardiorespiratory medicine: Integrating environmental health into clinical decision-making.

Low-carbon therapeutics in cardiorespiratory medicine: Integrating environmental health into clinical decision-making.

Journal: Respiratory medicine and research

Published: February 16, 2026

Impact of Immune Checkpoint Inhibitor-Combined Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer With Brain Metastases.

Impact of Immune Checkpoint Inhibitor-Combined Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer With Brain Metastases.

Journal: Clinical lung cancer

Published: January 28, 2026

Organized Lung Cancer Screening of Subjects Occupationally Exposed to Lung Carcinogens: The LUng Cancer Screening Occupational exposure Study Entry Findings.

Organized Lung Cancer Screening of Subjects Occupationally Exposed to Lung Carcinogens: The LUng Cancer Screening Occupational exposure Study Entry Findings.

Journal: JTO clinical and research reports

Published: November 10, 2025

A new tunable 3D alveolospheres model from human alveolar epithelial type 2 cells (AEC2) with reduced heterogeneity for studying cigarette smoke extract exposure.

A new tunable 3D alveolospheres model from human alveolar epithelial type 2 cells (AEC2) with reduced heterogeneity for studying cigarette smoke extract exposure.

Journal: Respiratory research

Published: November 05, 2025

Moving towards COPD control: Lessons, challenges, and the role of CONDOR, a new French respiratory research network.

Moving towards COPD control: Lessons, challenges, and the role of CONDOR, a new French respiratory research network.

Journal: Respiratory medicine and research

Published: November 02, 2025

Female pulmonologists experienced poorer health and reduced quality of life related to their professional activities.

Female pulmonologists experienced poorer health and reduced quality of life related to their professional activities.

Journal: ERJ open research

Published: October 10, 2025

3D Automated Segmentation of Bronchial Abnormalities on Ultrashort Echo Time MRI: A Quantitative MR Outcome in Cystic Fibrosis.

3D Automated Segmentation of Bronchial Abnormalities on Ultrashort Echo Time MRI: A Quantitative MR Outcome in Cystic Fibrosis.

Journal: Journal of magnetic resonance imaging : JMRI

Published: August 26, 2025

The Healthcare Resource Utilization of Patients with Refractory Chronic Cough Compared to Those with Non-Refractory Chronic Cough.

The Healthcare Resource Utilization of Patients with Refractory Chronic Cough Compared to Those with Non-Refractory Chronic Cough.

Journal: Lung

Published: August 09, 2025

Impact of prior immunotherapy on paclitaxel/bevacizumab in advanced non-squamous non-small cell lung cancer.

Impact of prior immunotherapy on paclitaxel/bevacizumab in advanced non-squamous non-small cell lung cancer.

Journal: Frontiers in oncology

Published: July 29, 2025

Real-World Use and Immunotherapy Rechallenge Outcomes with Nivolumab in Advanced Non-small Cell Lung Cancer in France: Interim Results of the LIST Study.

Real-World Use and Immunotherapy Rechallenge Outcomes with Nivolumab in Advanced Non-small Cell Lung Cancer in France: Interim Results of the LIST Study.

Journal: Oncology and therapy

Published: July 22, 2025

Showing 1-12 of 106

Last Updated: 09/26/2026